Recent studies have demonstrated that USP8‐mediated deubiquitylation of TβRII promotes tumor progression and immune suppression, thereby fostering a tumor‐permissive microenvironment in pancreatic cancer. The gene discussed is TGFBR2; the disease is neoplasm.